ArticleCancers2014

Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth.

Brian C Stagg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.